Position in CATX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$121,933
+$44,841 QoQ
Shares Held
29,241
+4.3% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $18,238,887,170 across 97 Medical Devices names. CATX ranks #65 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
15,596,897 | $5,124,984,375 | |
| 2 | MDT |
Medtronic plc
|
50,973,541 | $4,416,857,318 | |
| 3 | ABT |
Abbott Laboratories
|
26,767,099 | $2,748,178,043 | |
| 4 | BSX |
Boston Scientific Corp
|
33,350,157 | $2,092,722,344 | |
| 5 | EW |
Edwards Lifesciences Corp
|
21,744,712 | $1,741,316,529 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
8,964,669 | $638,105,129 | |
| 7 | DXCM |
Dexcom Inc
|
5,999,470 | $376,766,708 | |
| 8 | GMED |
Globus Medical Inc
|
2,595,308 | $223,611,733 |
All Filings in CATX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $121,933 | 29,241 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $77,092 | 28,034 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,496,703 | 436,357 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $2,573,349 | 748,067 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $729,428 | 342,455 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $475,452 | 149,045 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $332,575 | 24,912 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $200,077 | 20,068 | Shares | Defined | 2024-12-26 | |
| No filing history on record for this holder in this stock. | ||||||